Stockscreener 앱 받기
3.11
1.58%
-0.05
시간 외 거래:
3.05
-0.06
-1.93%
전일 마감가:
$3.16
열려 있는:
$3.16
하루 거래량:
49,150
Relative Volume:
0.48
시가총액:
$15.32M
수익:
-
순이익/손실:
$-43.10M
주가수익비율:
-0.3199
EPS:
-9.7212
순현금흐름:
$-36.82M
1주 성능:
-0.32%
1개월 성능:
-64.25%
6개월 성능:
-56.26%
1년 성능:
-71.34%
1일 변동 폭
$3.0601
$3.19
1주일 범위
$3.04
$3.23
52주 변동 폭
$3.00
$13.65
Tempest Therapeutics Inc Stock (TPST) Company Profile
명칭
Tempest Therapeutics Inc
전화
415-798-8589
주소
2000 SIERRA POINT PARKWAY, BRISBANE
TPST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
3.11 | 15.57M | 0 | -43.10M | -36.82M | -9.7212 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-08 | 개시 | Jefferies | Buy |
Tempest Therapeutics Inc 주식(TPST)의 최신 뉴스
Tempest Therapeutics (TPST) Stock Price, Quote, News & History - Benzinga
Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com - Investing.com Nigeria
Tempest Therapeutics Closes $4.3 Million Direct Offering - MarketScreener
Tempest Therapeutics closes $4.25 million registered direct offering - Investing.com
Tempest Therapeutics : Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - MarketScreener
Tempest Therapeutics, Inc. Completes Registered Direct Offering and Private Placement, Raising Approximately $4.25 Million - Quiver Quantitative
Tempest Announces Closing of Up To $8.35 Million Registered - GlobeNewswire
[8-K] Tempest Therapeutics, Inc. Reports Material Event | TPST SEC FilingForm 8-K - Stock Titan
Tempest Therapeutics Secures $4.25M in Direct Offering - MSN
Form 8-KCurrent report - ADVFN
Tempest Therapeutics stock falls after $4.25 million direct offering - MSN
[424B5] Tempest Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Form 424B5 Tempest Therapeutics, - StreetInsider
Tempest Therapeutics stock falls after $4.25 million direct offering By Investing.com - Investing.com UK
Tempest Therapeutics raises $4.25 million in registered direct offering - Investing.com
Tempest Therapeutics Inc (TPST) Performance and Fundamentals Dashboard tells a completely different story - setenews.com
Tempest Therapeutics raises $4.25 million in registered direct offering By Investing.com - Investing.com South Africa
Tempest Therapeutics (Nasdaq: TPST) prices $4.25M offering with $4.1M warrant upside - Stock Titan
Is Tempest Therapeutics Inc. stock ready for breakoutMarket Growth Report & Growth Oriented Trade Recommendations - newser.com
Will Tempest Therapeutics Inc. stock outperform growth indexesTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Tempest Therapeutics Announces New Leadership and Acquisition - MSN
Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs By Investing.com - Investing.com Australia
Check Out Tempest Therapeutics Inc (TPST)’s Trade Data Rather Than the Analysts’ Views - Setenews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Tempest Therapeutics stock plunges after all-stock acquisition By Investing.com - Investing.com Australia
What technical signals suggest for Tempest Therapeutics Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Will Tempest Therapeutics Inc. stock go up soonProduct Launch & Safe Entry Trade Signal Reports - newser.com
Tempest Therapeutics Stock Plummets Nearly 50% Amid Shareholder Dilution Fears Following CAR-T Acquisition - Markets Financial Content
Tempest gains CAR Ts for 65% of the company; stock drops - BioWorld MedTech
Why Tempest Therapeutics Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Tempest Therapeutics to acquire Factor Bioscience's CAR-T programs By Investing.com - Investing.com Nigeria
Is Tempest Therapeutics Inc. stock poised for growthWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction - MSN
Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs - Investing.com India
Why Tempest Therapeutics (TPST) Stock Is Down 45% Today - Benzinga
Tempest Therapeutics stock plunges after all-stock acquisition - Investing.com India
Is Tempest Therapeutics Inc. stock undervalued vs historical averages2025 Top Decliners & Expert Approved Trade Ideas - newser.com
Is Tempest Therapeutics Inc. stock cheap at current valuationJuly 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Tempest announces strategic acquisition of new dual-car T programs from Factor with simultaneous runway extension projected to mid 2027 - marketscreener.com
Tempest Therapeutics Announces Executive and Board Changes - TradingView
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 - The Globe and Mail
Tempest Therapeutics Inc (TPST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):